Prils Market Information by Type (Ramipril, Quinapril,
Cilazapril, & Benazepril), Application (Hypertension, Heart Failure, &
Chronic Kidney Disorders), & Region (Americas, Europe, Asia-Pacific, &
the Middle East & Africa) - Global Forecast till 2023
The report presents a detailed analysis of the Global Prils Market by providing readers
with a comprehensive overview of the market’s historical trajectory. The
leading drivers and restraints affecting the global Prils Market are assessed
in detail in the report. The historical impact of these drivers and restraints
is analyzed in context of the current impact of these factors and projections
are made for the likely impact of these drivers and restraints over the
forecast period. Various components of the global Prils Market are also studied
in the report and projections are made for the growth trajectory of each
distinct component from 2018 to 2023. The various segments and sub-segments
within the global Prils Market are studied in detail in the report. The study
also makes a detailed analysis of the major players operating in the global Prils
Market and provides pointers as to the likely strategies to be used by these
and other leading players in the market.
The Prils Market, comprising of ramipril, quinapril,
cilazapriil, and benazepril, is mainly driven by the growing demand for
hypertension and cardiac medication. Growing prevalence of smoking, high
consumption of high-fat junk foods, increasing sedentary lifestyles, etc. are
the major drivers propelling the rates of cardiac conditions through the roof.
This has given rise to a growing demand for medications to treat the same, thus
driving the demand for prils of various kinds. Kidney-related problems are also
on the rise, thus driving the demand from the Prils Market. The increasing
demand for prils for treating hypertension, cardiac disorders, and kidney
disorders is likely to be a major driver for the global Prils Market over the
forecast period. The increasing geriatric population is also likely to be a
major driver for the global Prils Market, as geriatric people are mostly
affected by cardiovascular problems and hypertension.
The increasing importance of generic drugs in the
healthcare sector in developed economies is also likely to be a major driver
for the global Prils Market, as this is likely to drive multifaceted growth of
the Prils Market in branded as well as generic drug development channels.
Competitive
Analysis:
Leading players in the global Prils Market include
Novartis AG, Canagen Pharmaceuticals Inc., Manus Aktteva Biopharma LLP, Merck
KGaA, Sun Pharmaceutical Industries Ltd., F. Hoffman-La Roche, Mylan NV, Pfizer
Inc., Lupin, and Aurobindo Pharma.
Segmentation:
The global Prils Market is segmented on the basis of
type, application, and region.
On the basis of type, the global Prils Market is
segmented into Ramipril, Quinapril, Cilazapril, and Benazepril. The Ramipril
segment holds the dominant share in the global Prils Market and is likely to
retain this position over the forecast period, as it is widely used in
hypertension, cardiac, and kidney medications.
By application, the global Prils Market is segmented
into hypertension, heart failure, chronic kidney disorders, and others.
Hypertension holds the largest share in the global Prils Market.
Regional Analysis:
The Americas is likely to dominate the global
Prils Market over the forecast period. The Americas segment held a dominant
38.8% share in the global Prils Market in 2017 and is likely to retain a
similar level of dominance over the forecast period. The Americas market for
prils is majorly driven by the strong presence of several leading API (active
pharmaceutical ingredient) manufacturers in North America. This has given the Prils
Market in North America a firm direction to grow, with local players aiming big
and trying to carve out a strong share in the market across the whole Americas
region. The growing geriatric population in North America, with the increasing
baby boomer population being the dominant demographic, is also likely to be a
major driver for the Prils Market in the region over the forecast period. The
increasing prevalence of hypertension, driven by increasing consumption of junk
food and increasing participation in sedentary lifestyles, is likely to be a
major driver for the global Prils Market in North America. The increasing
prevalence of diabetic kidney failure in North America is also likely to be a
major driver for the global Prils Market over the forecast period.
No comments:
Post a Comment